Skip to main content
SpringerLink
Log in

Overview of Sarcopenia

  • Chapter
  • First Online:
Book cover Sarcopenia – Age-Related Muscle Wasting and Weakness

Abstract

Some of the most serious consequences of ageing are its effects on skeletal muscle. ‘Sarcopenia’ involves a progressive age-related loss of muscle mass and associated muscle weakness that renders frail elders susceptible to serious injury from sudden falls and fractures and losing their functional independence. Not surprisingly, sarcopenia is a significant global public health problem, especially in the developed world. There is an urgent need to better understand the mechanisms underlying age-related muscle wasting and to develop therapeutic strategies that can attenuate, prevent, or ultimately reverse skeletal muscle wasting and weakness. Research and development in academic and research institutions and in large and small pharma is being directed to sarcopenia and related issues to develop and evaluate novel therapies. This book provides the latest information on sarcopenia from leading international researchers studying the cellular and molecular mechanisms underlying age-related changes in skeletal muscle and identifying strategies to combat sarcopenia and related muscle wasting conditions and neuromuscular disorders. The range of interventions for sarcopenia is extensive and not all can be covered in this first volume. While not covering every possible theme, the selected topics provide important insights into the some of the mechanisms underlying sarcopenia and serve as the basis for subsequent complementary volumes that will eventually provide a definitive resource for understanding age-related muscle wasting and weakness and therapeutic approaches to combat sarcopenia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aagaard, P., Suetta, C., Caserotti, P., Magnusson, S. P., Kjær, M. (2010). Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scandinavian Journal of Medicine & Science in Sports, 20, 49–64.

    Article  CAS  Google Scholar 

  • Arnold, A. S., Egger, A., Handschin, C. (2010). PGC-1alpha and myokines in the aging muscle – a mini-review. Gerontology (in press) DOI: 10.1159/000281883.

    Google Scholar 

  • Bain, J. (2010). Testosterone and the aging male: to treat or not to treat? Maturitas, 66, 16–22.

    Article  CAS  PubMed  Google Scholar 

  • Borst, S. E. (2004). Interventions for sarcopenia and muscle weakness in older people. Age and Ageing, 33, 548–555.

    Article  PubMed  Google Scholar 

  • Buford, T. W., Anton, S. D., Judge, A. R., Marzetti, E., Wohlgemuth, S. E., Carter, C. S., Leeuwenburgh, C., Pahor, M., Manini, T. M. (2010). Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Research Reviews, 9, 369–383.

    Google Scholar 

  • Combaret, L., Dardevet, D., Béchet, D., Taillandier, D., Mosoni, L., Attaix, D. (2009). Skeletal muscle proteolysis in aging. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 37–41.

    Article  PubMed  Google Scholar 

  • Cristea, A., Korhonen, M. T., Häkkinen, K., Mero, A., Alén, M., Sipilä, S., Viitasalo, J. T., Koljonen, M. J., Suominen, H., Larsson, L. (2008). Effects of combined strength and sprint training on regulation of muscle contraction at the whole-muscle and single-fibre levels in elite master sprinters. Acta Physiologica, 193, 275–289.

    Article  CAS  PubMed  Google Scholar 

  • Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J. P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., Zamboni, M.(2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, April 13, 1–12.

    Google Scholar 

  • Edström, E., Altun, M., Hägglund, M., Ulfhake, B. (2006). Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 61, 663–674.

    Google Scholar 

  • Evans, W. J. (1995). What is sarcopenia? The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 50A, 5–8.

    Google Scholar 

  • Evans, W. J. (2010). Skeletal muscle loss: cachexia, sarcopenia, and inactivity. The American Journal of Clinical Nutrition, 91, 1123S–1127S.

    Article  CAS  PubMed  Google Scholar 

  • Evans, W. J. & Campbell, W. W. (1993). Sarcopenia and age-related changes in body composition and functional capacity. Journal of Nutrition 123(2 Suppl), 465–468.

    Google Scholar 

  • Gullett, N. P., Hebbarm G., Ziegler, T. R. (2010). Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. The American Journal of Clinical Nutrition, 91, 1143S–1147S.

    Article  CAS  PubMed  Google Scholar 

  • Janssen, I., Heymsfield, S. B., Ross, R. (2002). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society, 50, 889–896.

    Article  PubMed  Google Scholar 

  • Janssen, I., Shepard, D. S., Katzmarzyk, P. T., Roubenoff, R. (2004). The healthcare costs of sarcopenia in the United States. Journal of the American Geriatrics Society, 52, 80–85.

    Article  PubMed  Google Scholar 

  • Koopman, R., Ryall, J. G., Church, J. E., Lynch, G. S. (2009). The role of b-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 601–606.

    Article  CAS  PubMed  Google Scholar 

  • Korhonen, M. T., Mero, A., Suominen, H. (2003). Age-related differences in 100-m sprint performance in male and female master runners. Medicine and Science in Sports and Exercise, 35, 1419–1428.

    Article  PubMed  Google Scholar 

  • Korhonen, M. T., Cristea, A., Alén, M., Häkkinen, K., Sipilä, S., Mero, A., Viitasalo, J. T., Larsson, L., Suominen, H. (2006). Aging, muscle fiber type, and contractile function in sprint-trained athletes. Journal of Applied Physiology, 101, 906–917.

    Article  CAS  PubMed  Google Scholar 

  • Kovacheva, E. L., Sinha-Hikim, A. P., Shen, R., Sinha, I., Sinha-Hikim, I. (2010). Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch and Akt signalling pathways. Endocrinology, 151, 628–638.

    Article  CAS  PubMed  Google Scholar 

  • Lynch, G. S. (2002). Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle. Expert Opinin on Therapeutic Patents, 12, 11–27.

    Article  CAS  Google Scholar 

  • Lynch, G. S. (2004a). Tackling Australia’s future health problems: developing strategies to combat sarcopenia–age-related muscle wasting and weakness. Internal Medicine Journal, 34, 294–296.

    Article  CAS  PubMed  Google Scholar 

  • Lynch, G. S. (2004b). Emerging drugs for sarcopenia: age-related muscle wasting. Expert Opinion on Emerging Drugs, 9, 345–361.

    Article  CAS  PubMed  Google Scholar 

  • Lynch, G. S. (2008). Update on emerging drugs for sarcopenia – age-related muscle wasting. Expert Opinion on Emerging Drugs, 13, 655–673.

    Article  CAS  PubMed  Google Scholar 

  • Lynch, G. S, Schertzer, J. D, Ryall, J. G. (2007). Therapeutic approaches for muscle wasting disorders. Pharmacology & Therapeutics, 113, 461–487.

    Article  CAS  Google Scholar 

  • Meng, S. J. & Yum L. J. (2010). Oxidative stress, molecular inflammation and sarcopenia. International Journal of Molecular Sciences, 11, 1509–1526.

    Article  CAS  PubMed  Google Scholar 

  • Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., Fearon, K. C., Laviano, A., Maggio, M., Fanelli, F. R., Schneider, S. M., Schols, A., Sieber, C. C. (2010). Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clinical Nutrition, 29, 154–159.

    Article  CAS  PubMed  Google Scholar 

  • Narici, M. V. & Maffulli, N. (2010). Sarcopenia: characteristics, mechanisms and functional ­significance. British Medical Bulletin, 95, 139–159.

    Google Scholar 

  • Orr, R. & Fiatarone Singh, M. (2004). The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs, 64, 725–750.

    Article  CAS  PubMed  Google Scholar 

  • Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A., Giorgino, F. (2010). The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying ­age-related skeletal muscle wasting and osteoporosis. The Journal of Endocrinology, 205, 201–210.

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg, I. (1989). Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. American Journal of Clinical Nutrition 50, 1231–1233.

    Google Scholar 

  • Runge, M., Rittweger, J., Russo, C. R., Schiessl, H., Felsenberg, D. (2004). Is muscle power output a key factor in the age-related decline in physical performance? A comparison of muscle cross section, chair-rising test and jumping power. Clinical Physiology and Functional Imaging 24, 335–340.

    Google Scholar 

  • Ryall, J. G., Schertzer, J. D., Lynch, G. S. (2008). Cellular and molecular mechanisms ­underlying age-related skeletal muscle wasting and weakness. Biogerontology, 9, 213–228.

    Article  CAS  PubMed  Google Scholar 

  • Scicchitano, B. M., Rizzuto, E., Musaro, A. (2009). Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging, 1, 451–457.

    CAS  PubMed  Google Scholar 

  • Thompson, D. D. (2007). Aging and sarcopenia. Journal of Musculoskeletal & Neuronal Interactions, 7, 344–345.

    CAS  Google Scholar 

  • Tseng, B. S., Marsh, D. R., Hamilton, M. T., Booth, F. W. (1995). Strength and aerobic training attenuate muscle wasting and improve resistance to the development of disability with aging. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 50A, 113–119.

    Google Scholar 

  • Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., Moraes, C. T. (2009). Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proceedings of the National Academy of Sciences of the United States of America, 106, 20405–20410.

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi, J., Mishima, C., Nakayama, S., Ishii, N. (2009). Force-velocity, force-power ­relationships of bilateral and unilateral leg multi-joint movements in young and elderly women. Journal of Biomechanics, 42, 2151–2157.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Basic and Clinical Myology Laboratory, The University of Melbourne, Parkville, Victoria, Australia

    Gordon S. Lynch

Authors
  1. Gordon S. Lynch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gordon S. Lynch .

Editor information

Editors and Affiliations

  1. , Department of Physiology, The University of Melbourne, Melbourne, 3100, Victoria, Australia

    Gordon S. Lynch

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Lynch, G.S. (2011). Overview of Sarcopenia. In: Lynch, G. (eds) Sarcopenia – Age-Related Muscle Wasting and Weakness. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9713-2_1

Download citation

Publish with us

Policies and ethics

Search

Navigation